DK167907B1 - Anvendelse af micellulaere partikler til fremstilling af farmaceutiske praeparater til maalrettet tilfoersel til tumorer i mennesker - Google Patents

Anvendelse af micellulaere partikler til fremstilling af farmaceutiske praeparater til maalrettet tilfoersel til tumorer i mennesker Download PDF

Info

Publication number
DK167907B1
DK167907B1 DK484685A DK484685A DK167907B1 DK 167907 B1 DK167907 B1 DK 167907B1 DK 484685 A DK484685 A DK 484685A DK 484685 A DK484685 A DK 484685A DK 167907 B1 DK167907 B1 DK 167907B1
Authority
DK
Denmark
Prior art keywords
particles
micellular
pure
use according
vesicles
Prior art date
Application number
DK484685A
Other languages
Danish (da)
English (en)
Other versions
DK484685A (da
DK484685D0 (da
Inventor
Cary Arnett Presant
Richard Thomas Proffitt
Original Assignee
Vestar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vestar Inc filed Critical Vestar Inc
Publication of DK484685D0 publication Critical patent/DK484685D0/da
Publication of DK484685A publication Critical patent/DK484685A/da
Application granted granted Critical
Publication of DK167907B1 publication Critical patent/DK167907B1/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Optics & Photonics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK484685A 1984-11-23 1985-10-22 Anvendelse af micellulaere partikler til fremstilling af farmaceutiske praeparater til maalrettet tilfoersel til tumorer i mennesker DK167907B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67420184A 1984-11-23 1984-11-23
US67420184 1984-11-23

Publications (3)

Publication Number Publication Date
DK484685D0 DK484685D0 (da) 1985-10-22
DK484685A DK484685A (da) 1986-05-24
DK167907B1 true DK167907B1 (da) 1994-01-03

Family

ID=24705713

Family Applications (1)

Application Number Title Priority Date Filing Date
DK484685A DK167907B1 (da) 1984-11-23 1985-10-22 Anvendelse af micellulaere partikler til fremstilling af farmaceutiske praeparater til maalrettet tilfoersel til tumorer i mennesker

Country Status (8)

Country Link
EP (1) EP0182131B1 (de)
JP (1) JPS61158933A (de)
KR (1) KR860004315A (de)
AT (1) ATE70456T1 (de)
CA (1) CA1267840A (de)
DE (1) DE3584948D1 (de)
DK (1) DK167907B1 (de)
IE (1) IE58124B1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3710371A1 (de) * 1987-03-28 1988-10-13 Dornier Medizintechnik Zerstoerung von krankhaft veraenderten gewebezellen
JPH09504797A (ja) * 1993-11-08 1997-05-13 ペプチド デリバリー システムズ プロプリエタリイ リミテッド ラベルされた診断用組成物と，その使用方法
ATE281886T1 (de) * 1994-01-21 2004-11-15 Sirtex Medical Ltd Yttria partikelförmiges gut
US6537518B1 (en) 1994-01-21 2003-03-25 Sirtex Medical Limited Particulate material
AUPP032097A0 (en) * 1997-11-11 1997-12-04 Peptide Delivery Systems Pty Ltd Improved labelled diagnostic compositions and methods of their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992513A (en) * 1975-01-07 1976-11-16 Atomic Energy Of Canada Limited Labelled phospholipid material colloidially dispersed and sized to localize at preselected organs
US4310505A (en) * 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances

Also Published As

Publication number Publication date
EP0182131B1 (de) 1991-12-18
ATE70456T1 (de) 1992-01-15
KR860004315A (ko) 1986-06-20
DK484685A (da) 1986-05-24
JPH0582369B2 (de) 1993-11-18
EP0182131A1 (de) 1986-05-28
DK484685D0 (da) 1985-10-22
DE3584948D1 (de) 1992-01-30
IE852601L (en) 1986-05-23
IE58124B1 (en) 1993-07-14
JPS61158933A (ja) 1986-07-18
CA1267840A (en) 1990-04-17

Similar Documents

Publication Publication Date Title
US5019369A (en) Method of targeting tumors in humans
Luo et al. Intrabilayer 64Cu labeling of photoactivatable, doxorubicin-loaded stealth liposomes
RU2497499C2 (ru) Новые термочувствительные липосомы, содержащие терапевтические агенты
US5441745A (en) Method of delivering micellular particles encapsulating chemotherapeutic agents to tumors in a body
KR20100135312A (ko) 합성 중합체의 방사성 표지화 방법
KR20130019029A (ko) 병용요법을 위한 방사핵종 및 세포독성제를 봉입한 리포좀
US6274115B1 (en) Method of targeting a specific location in a body using phospholipid and cholesterol liposomes which encapsulate an agent
Hoshi et al. Internal iliac arterial infusion chemotherapy for rabbit invasive bladder cancer
DK167907B1 (da) Anvendelse af micellulaere partikler til fremstilling af farmaceutiske praeparater til maalrettet tilfoersel til tumorer i mennesker
DK167556B1 (da) Anvendelse af en micellepartikelkomposition, hvori partiklerne i sig selv har indkapslet et kemoterapeutisk middel, til fremstilling af et intravenoest indgiveligt farmaceutisk praeparat til indfoerelse af partikelkompositionen og det kemoterapeutiske middel i tumorceller
US6241962B1 (en) Radiopharmaceutical compositions and matrices and uses thereof
Tonetti et al. Use of glutaraldehyde treated autologous human erythrocytes for hepatic targeting of doxorubicin
US11266755B2 (en) Development and application of tumor diagnostic radioactive probe targeting folic acid receptor
CA2259343C (en) Novel radiopharmaceutical compositions and matrices and uses thereof
US9717808B2 (en) Kit for preparation of target radiopharmaceuticals and method of using it
US20080226546A1 (en) Kit for preparation of nano-targeted liposome drug in combined radionuclide therapy and chemotherapy
Wang et al. Intraoperative therapy with liposomal drug delivery: Retention and distribution in human head and neck squamous cell carcinoma xenograft model
US8986731B2 (en) Pegylated liposomal formulations of hydrophobic photosensitizers for photodynamic therapy
AU615184B2 (en) Method of targeting tumors in humans
JP2018197208A (ja) 一酸化窒素内包バブルリポソーム及びその利用
Story Liposomal delivery of glucoCEST and 2-deoxyglucoCEST reagents
Lepareur (188) Re-loaded lipid nanocapsules as a promising radiopharmaceutical carrier for internal radiotherapy of malignant gliomas
Tamura Evaluation of drug distribution after port-catheter implantation for hepatic arterial infusion chemotherapy by means of SPECT/CT fusion imaging
Mantravadi et al. Treatment of Hepatic Malignancies by Intravascular Administration of Radioisotopes

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired